Health Care & Life Sciences » Medical Equipment & Supplies | Medite Cancer Diagnostics Inc.

Medite Cancer Diagnostics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
24.00
10,983.00
9,887.00
9,238.00
6,813.00
Cost of Goods Sold (COGS) incl. D&A
82.00
7,334.00
6,261.00
5,822.00
6,944.00
Gross Income
58.00
3,649.00
3,626.00
3,416.00
131.00
SG&A Expense
1,196.00
4,043.00
4,225.00
5,077.00
6,349.00
EBIT
1,254.00
-
599.00
-
6,480.00
Unusual Expense
436.00
-
-
-
158.00
Non Operating Income/Expense
-
75.00
22.00
60.00
189.00
Interest Expense
105.00
276.00
204.00
694.00
849.00
Pretax Income
923.00
595.00
781.00
2,295.00
7,298.00
Income Tax
-
104.00
78.00
132.00
487.00
Consolidated Net Income
923.00
699.00
859.00
2,163.00
6,811.00
Net Income
923.00
699.00
859.00
2,163.00
6,811.00
Net Income After Extraordinaries
923.00
699.00
859.00
2,163.00
6,811.00
Net Income Available to Common
1,189.00
808.00
937.00
2,254.00
6,902.00
EPS (Basic)
1.00
4.00
0.05
0.11
0.26
Basic Shares Outstanding
1,972.10
181.20
20,194.70
21,423.50
26,436.10
EPS (Diluted)
0.60
4.46
0.05
0.11
0.26
Diluted Shares Outstanding
1,972.10
181.20
20,194.70
21,423.50
26,436.10
EBITDA
1,180.00
224.00
422.00
1,447.00
6,187.00
Preferred Dividends
266.00
109.00
78.00
91.00
91.00

About Medite Cancer Diagnostics

View Profile
Address
4203 SW 34th Street
Orlando Florida 32811
United States
Employees -
Website http://www.medite-group.com
Updated 07/08/2019
MEDITE Cancer Diagnostics, Inc. is a medical technology company which engages in cancer diagnostics instruments and consumables for histology and cytology laboratories. It specializes in developing, manufacturing, and marketing of molecular biomarkers premium medical devices and consumables for detection, risk assessment and diagnosis of cancer, precancerous conditions, and related diseases. It operates through the following segments: United States, Germany, and Poland.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.